RPCI CancerTalk
Friday, February 8, 2013 - 11:51am
The Gynecologic Oncology Group (GOG) has announced the results of a new study that may change the standard of care for women with advanced or recurrent cervical cancer. The findings of this clinical trial were recently released by the National Cancer Institute (NCI). One of the goals of this GOG study was to evaluate the effectiveness of a new treatment called bevacizumab (brand name AvastinTM). This agent is believed to block the growth of nutrient-supplying blood vessels that form in cancerous tumors....
Tuesday, February 5, 2013 - 3:45pm
The most recent edition of Roswellness Radio focused on cancer and infections. Brahm Segal, MD, Chief, Infectious Diseases and Kimberly Hinckley, RN, BSN, CIC, Senior Infection Prevention and Control Coordinator, discussed why cancer patients are at increased risk of developing infections. The pair also explained exactly how they work together to protect both the patients and staff at RPCI.
The New York State Department of Health reports that there has been a widespread increase in reported cases...
Friday, February 1, 2013 - 11:42am
With each new year comes a sense of hope. An opportunity to set ambitious goals, break bad habits and learn from past mistakes. It’s a free pass at a fresh start with endless possibilities for growth. But when you’re battling cancer, the promise of a new year is stifled by the stress of a life threatening illness.
AYA cancer survivors Corrie O’Hara and Mary Flanigan battled cancer at a crucial time in their lives. In the midst of high school homecoming and college preparations, a shocking...
Thursday, January 31, 2013 - 3:36pm
HIPEC Cytoreduction/Hyperthermic Intraperitoneal Chemoperfusion is the process of directly applying chemotherapy agents to abdominal cancers. Roswell Park has been utilizing HIPEC for about ten years with promising outcomes. John Kane III, MD, Chief of the Melanoma/Sarcoma Service, and Joseph Skitzki, MD, Assistant Professor of Surgical Oncology and Associate Member of the Department of Immunology, visited Roswellness Radio last Sunday to describe HIPEC in greater detail, how it...
Tuesday, January 29, 2013 - 9:34am
One week before my brother was set to study business in Singapore this summer, Dr. Metchler delivered his alarming news.
After nearly a year of clear MRIs, Dr. Metchler was seeing something new. The images he’d received in May seemed to suggest a new growth of malignant cells deep inside David’s brain.
My memory of this moment is admittedly fuzzy, but I’m sure our faces betrayed the panic and sadness we felt as we jumped to what felt like an obvious conclusion: summer in Singapore was out.
But Dr. Metchler was going on. “So, we’ll...
Saturday, January 26, 2013 - 8:00am
Although rare, about 38,000 Americans die from pancreatic cancer each year, making it the fourth deadliest type of cancer in the United States. In an effort to slow the death rate of this disease, doctors and researchers have worked feverishly to come up with advancements in treatment.
Roswell Park recently participated in a promising Phase III clinical trial, led by Dr. Daniel Von Hoff of the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare in Arizona. The results of the MPACT (Metastatic Pancreatic...
Thursday, January 24, 2013 - 9:11am
The RPCI Donor Center's Maria Turner appeared on Roswellness Radio on Sunday to discuss platelet donations. Maria talked about the need for platelet donations and why they are so important to cancer patients. Joining Maria was longtime platelet donor Nancy, who discussed her experience as a regular donor at RPCI. The pair also explained who exactly can give platelets and how to get in touch with the Donor Center.
